Effects of a mushroom mycelium extract on the treatment of prostate cancer

Urology

Volumn 60, Issue 4, 2002, Pages 640-644

  DeVere White, Ralph W ^a   Hackman, Robert M ^a   Soares, Stephanie E ^a   Beckett, Laurel A ^b   Sun, Buxiang ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b School of Medicine   (United States)

^c Amino Up Chemical Co   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MUSHROOM MYCELIUM EXTRACT; PLANT EXTRACT; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER THERAPY; CAPSULE FILLING; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LENTINUS EDODES; MAJOR CLINICAL STUDY; MALE; MOUSE; MYCELIUM; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AGED; ANIMALS; COMPLEMENTARY THERAPIES; HUMANS; MALE; MICE; MICE, NUDE; MYCELIUM; PILOT PROJECTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SHIITAKE MUSHROOMS; TREATMENT OUTCOME;

EID: 0036775712     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)01856-3     Document Type: Article

References (16)

1. Coss R., McGrath P., Caggiano V. Alternative care patient choices for adjunct therapies with a cancer center . Cancer Pract. 6:1998;176-181.
2. Cassileth B.R. Overview of alternative/complementary medicine. Cancer Pract. 6:1998;245.
3. Barnes J., Abbot N.C., Harkness E.F., et al. Articles on complementary medicine in the mainstream medical literature. Arch Intern Med. 159:1999;1721-1725.
4. Eisenberg D.M., Kessler R.C., Foster C., et al. Unconventional medicine in the United States. N Engl J Med. 328:1993;246-252.
5. Ernst E., Cassileth B.R. The prevalence of complementary/alternative medicine in cancer. Cancer. 83:1998;777-782.
6. Nam R.K., Fleshner N., Rakovitch E., et al. Prevalence and patterns of the use of complementary therapies among prostate cancer patients an epidemiological analysis . J Urol. 161:1999;1521-1524.
7. Chang R. Functional properties of edible mushrooms. Nutr Rev. 54(11 Pt2):1996;S91-S93.
8. Borchers A.T., Stern J.S., Hackman R.M., et al. Mushrooms, tumors, and immunity. Proc Soc Exp Biol Med. 221:1999;281-293.
9. Laird N.M., Ware J.H. Random-effects models for longitudinal data. Biometrics. 38:1982;963-974.
10. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group . The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 330:1994;1029-1035.
11. Heinonen O.P., Albanes D., Virtamo J., et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene incidence and mortality in a controlled trial . J Natl Cancer Inst. 90:1998;440-446.
12. Clark L.C., Combs G.F. Jr, Turnbull B.W., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin a randomized controlled trial . JAMA. 276:1996;1957-1963.
13. Pinto J.T., Qiao C., Xing J., et al. Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture. Am J Clin Nutr. 66:1997;398-405.
14. Aldercreutz H., Markkanen H., Watanabe S. Plasma concentrations of phyto-estrogens in Japanese men. Lancet. 342:1993;1209-1210.
15. Giovannucci E., Ascherio A., Rimm E.B., et al. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst. 87:1995;1767-1776.
16. Shimada H., Tyler V.E., McLaughlin J.L. Biologically active acylglycerides from the berries of saw-palmetto (Serenoa repens). J Nat Prod. 60:1997;417-418.